SUMMARY OF PRODUCT CHARACTERISTICS. Active Ingredient Buserelin acetate (INN)

Similar documents
Buserelin animedica mg/ml Injektionslösung für Rinder, Pferde, Kaninchen

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised

PHARMACOLOGY AND TOXICOLOGY:

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

Leptospirosis has changed. Here's how to meet the new threat

Orgalutran 0.25 mg/0.5 ml solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/16

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/17

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Health Products Regulatory Authority

SUMMARY OF PRODUCT CHARACTRISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Bovine Herpes Virus type 1 (BoHV-1), strain Difivac (ge-negative), to induce a geometric mean seroneutralizing titre of at least 1:160 in cattle

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

1. NAME OF THE MEDICINAL PRODUCT. Gonapeptyl 0.1 mg/1 ml solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

SUMMARY OF PRODUCT CHARACTERISTICS

ENCEFAL-VAC SUMMARY OF PRODUCT CHARACTERISTICS

Irish Medicines Board

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

REPRODUCTION & GENETICS. Hormones

Health Products Regulatory Authority

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

[Version 8, 10/2012] ANNEX I SUMMARY OF PROPOSED PRODUCT CHARACTERISTICS

ANNEX III LABELLING AND PACKAGE LEAFLET

SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

PART 1 B SUMMARY OF PRODUCT CHARACTERISTICS, LABELLING AND PACKAGE LEAFLET

SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Health Products Regulatory Authority

SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I. Marketing Authorisation Holder (Name and address): Reference Member State:

NEW ZEALAND DATA SHEET

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Summary of Product Characteristics

[Version 8.1, 01/2017] ANNEX I. SUMMARY OF PRODUCT CHARACTERISTICS

Package leaflet: Information for the patient. Orgalutran 0.25 mg/0.5 ml solution for injection Ganirelix

SUMMARY OF PRODUCT CHARACTERISTICS. Albuman 40 g/l is a solution containing 40 g/l (4%) of total protein of which at least 95% is human albumin.

ADT Booster Data Sheet

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTRISTICS

GONADOTROPHIN (LUTEINISING)- RELEASING HORMONE AND ANALOGUES (GnRH OR LHRH)

Summary of product characteristics As per Annexure C. SUMMARY OF PRODUCT CHARACTERISTICS Doc. No. SPC/71108 Ver.1

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Institute for State Control of Veterinary Biologicals and Medicines Ústav pro státní kontrolu veterinárních biopreparátů a léčiv

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

3. PHARMACEUTICAL FORM Solution for infusion. A clear, slightly viscous liquid; it is almost colourless, yellow, amber or green.

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

1. During the follicular phase of the ovarian cycle, the hypothalamus releases GnRH.

SUMMARY OF PRODUCT CHARACTERISTICS 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Summary of product characteristics As per Annexure C. SUMMARY OF PRODUCT CHARACTERISTICS Doc. No. SPC/71108 Ver.1

Pergoveris 150IU/75IU

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

This vaccine is indicated for the prevention of poliomyelitis in infants, children and adults, for primary and booster vaccinations.

SUMMARY OF PRODUCT CHARACTERISTICS

DATA SHEET. Product Summary. 1. Trade Name of Medicinal Product. Protamine Sulphate Injection BP. 2. Qualitative and Quantitative Composition

CERVARIX GlaxoSmithKline

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Botulinum Toxin Type A for Injection Ph.Eur. Brand Name: BOTO GENIE

Fluarix NH. 1. NAME OF MEDICINAL PRODUCT Fluarix NH Influenza vaccine (split virion, inactivated)

SUMMARY OF PRODUCT CHARACTERISTICS

Health Products Regulatory Authority

PART 1.B SPC, LABELLING AND PACKAGE LEAFLET

Aminosteril N-Hepa 8%, solution for infusion. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

SUMMARY OF PRODUCT CHARACTERISTICS

Advanced Non-Cycling Program. Health

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Time / days. Explain how the release of FSH is controlled by negative feedback.

SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT

breeders really don t want to miss!!!

Health Products Regulatory Authority

SUMMARY OF PRODUCT CHARACTERISTICS. Each ml of solution for infusion contains 10 mg of paracetamol.

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Fasturtec 1.5 mg/ml powder and solvent for concentrate for solution for infusion.

Transcription:

1 (5) SUMMARY OF PRODUCT CHARACTERISTICS 1. Name of the veterinary medicinal product Receptal ad us. vet. 2. Qualitative and quantitative composition 1 ml contains Active Ingredient Buserelin acetate (INN) equivalent to Buserelin 0,0042 mg 0,004 mg Excipients: Benzyl alcohol (Ph. Eur., NF.) Sodium chloride (Ph. Eur., USP) Sodium dihydrogen phosphate 1 H 2 O (USP) Sodium hydroxide (BP, ÖAB, NF ) Water for injection (Ph. Eur., USP ) 3. Pharmaceutical form Injectable solution 4. Pharmacological properties Buserelin is a peptide hormone which is chemically analogous to the releasing hormone (RH) of the luteinising hormone (LH) and follicle stimulating hormone (FSH) thus a gonadotrophine releasing hormone (GnRH) analogue. The mode of action of Receptal corresponds to the physiologicendocrinological action of the naturally occurring gonadotrophin releasing hormone: GnRH leaves the hypothalamus via the hypophyseal portal vessels and enters the anterior lobe of the hypophysis. Here it induces the secretion of the two gonadotrophins FSH and LH into the peripheral blood stream. These then act physiologically to cause maturation of ovarian follicles, ovulation and luteinization in the ovary.

2 (5) Buserelin is rapidly eliminated from the plasma after intravenous administration, its initial half-life being 3-4.5 minutes in rats and 12 minutes in guinea pigs. It accumulates in liver, kidneys and hypophysis; high concentrations being found in hypophyseal tissue after about 60 minutes. The inactivation of buserelin by enzymatic breakdown (peptidases) can be demonstrated in the hypothalamus and hypophysis and in liver and kidneys. 5. Clinical particulars 5.0 Target species Cows, mares, rabbits and trout 5.1 Indication for use Reduced fertility by ovarian dysfunction, induction of ovulation and improvement of conception rate. Cow: Cystic ovaries with and without symptoms of nymphomania Delayed ovulation Anovulation after artificial insemination and oestrus synchronization Prophylaxis of fertility disorders by early induction of cycle post partum. Mare: Cystic ovarian disorders with and without prolonged or continuous heat Ovulation induction Fixing time of ovulation and service Prolonged or continuous heat Rabbit: Ovulation induction at post partum insemination

3 (5) Rainbow trout: Facilitate stripping in rainbow trout in spawning condition. Reduce mortality due to egg binding. 5.2 Contra indications 5.3 Undesirable effects Unknown 5.4 Special precautions for use 5.5 Use during pregnancy and lactation Can be administered to animals at any stage of pregnancy and lactation 5.6 Interactions with other medicaments No interaction known 5.7 Posology and method of application Cows: Cystic ovaries with and without symptoms of nymphomania Delayed ovulation Anovulation after artificial insemination Prophylaxis of fertility disorders by early induction of cycle post partum Mares: Cystic, ovarian disorders Ovulation induction 10 ml 2 times repeated after 24 h 10 ml Rabbit Ovulation induction at post

4 (5) partum insemination 0,2 ml 0,2 ml 5.8 Overdose 5.9 Warnings Rainbow trout: - to facilitate stripping in spawning condition 0.75 1.0ml/kg bw - to reduce mortality due to egg binding 0.75 1.0ml/kg bw The preferred route of administration for Receptal is intramuscular injection, but it may also be injected intravenously or subcutaneously. No specific overdose reactions known 5.10 Withdrawal period 5.11 Protection of operators 6. Pharmaceutical particulars 6.1 Incompatibilities 6.2 Shelf life 5 years 6.3 Special precautions for storage Store in a cool place below 25 C, protected from light.

5 (5) 6.4 Nature and contents of container Colourless multi-dose vials made of glass, sealed with butyl rubber stoppers and aluminium caps. Box with 5 bottles containing 10 ml each 6.5 Name and address of the licence holder Intervet International B.V: Wim de Korverstraat 55 PO Box 31 5830 Boxmeer The Netherlands Name and address of manufacturer Intervet International GmbH Feldstraße 1a D-85716 Unterschleißheim Germany 6.6 Special precautions for the disposal of empty containers or waste product